Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA FY 1990

Executive Summary

FDA FY 1990 budget: House/Senate conferees tentatively agreed Oct. 5 to a compromise budget providing a total of $ 594.2 mil., including: $ 560.3 mil. for salaries and expenses; $ 8.35 mil. for buildings and facilities and $ 25.6 mil. for rental payments. Compromise also allocates $ 56.9 mil. for AIDS activities. The compromise rejects the Administration's proposal that $ 100 mil. of the FDA budget be derived from "user fees." Report language will include a discussion of the agency's generic drug review program.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS016347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel